Will the new cancer vaccine survive RFK Jr’s America?

单集文稿 ...

• 00:00

  It was 1997 at the University of Pennsylvania in Philly.

• 00:04

  A Hungarian-American scientist by the name of Dr. Katalin Kariko was wandering the halls looking for a copy machine.

• 00:10

  And when she found one, she came across another researcher.

• 00:13

  They struck up a conversation.

• 00:15

  And so I was bragging that I'm working with RNA,

• 00:18

  and then he was telling me that he want to develop a vaccine.

• 00:23

  And that's how, you know, we started.

• 00:25

  Dr. Kariko and her research partner would go on to spend years working

• 00:29

  together on what was sometimes a scientific dead end, an mRNA vaccine.

• 00:34

  For years, their efforts amounted to little.

• 00:37

  But in 2023, after the development of the COVID vaccines

• 00:40

  that used mRNA technology, they were awarded the Nobel Prize for Medicine.

• 00:46

  Together, they have saved millions of lives, prevented severe COVID-19, reduced the overall disease burden.

• 00:53

  And enable societies to open up again.

• 00:58

  Last week, there was another watershed moment from that same mRNA technology, a potential cancer vaccine.

• 01:05

  And yet the news comes in a tough climate for vaccines.

• 01:09

  Last year, the U.S.

• 01:10

  Health and Human Services Secretary, RFK Jr., cut half a billion dollars of funding into mRNA research.

• 01:17

  From the BBC, I'm Asma Khalid in Washington, D.C. And today on The Global Story,

• 01:23

  the new skin cancer vaccine and the promise and politics of mRNA technology.

• 全部文稿